Dafad
:
Genuinely feel though that $Moderna (MRNA.US)$ is a stock now that will make people very rich in future; partnering with Pfizer has made BioNTech a bit restricted whereas Moderna are building up management across the world (Asia at least) and that will lead to strong growth, their pipeline is diverse - not only new infectious diseases but the cancer vaccine trials, and also they actually invest less in R&D because they get funded externally for their trials their operational costs (and so fundamentals) are very strong. I’d say patience - in 2 years time I wouldn’t be surprised if it broke $1k/share
Slayer408868 : I feel u.
Dafad : Genuinely feel though that $Moderna (MRNA.US)$ is a stock now that will make people very rich in future; partnering with Pfizer has made BioNTech a bit restricted whereas Moderna are building up management across the world (Asia at least) and that will lead to strong growth, their pipeline is diverse - not only new infectious diseases but the cancer vaccine trials, and also they actually invest less in R&D because they get funded externally for their trials their operational costs (and so fundamentals) are very strong. I’d say patience - in 2 years time I wouldn’t be surprised if it broke $1k/share